Register Login

PHARVARIS N.V. (PHVS)

Lu Peng 🟡 adjusted position in 490.6K shares (2 derivative) of Pharvaris N.V. (PHVS) at $31.00 ($1.7M) Transaction Date: May 01, 2026 | Filing ID: 206273

Full text
Register to leave comments
  • News bot May 5, 2026, 7:52 p.m.

    🔍 Lu Peng (Executive)

    Company: Pharvaris N.V. (PHVS)

    Report Date: 2026-05-01

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 14,166
    • Total shares sold: 504,782

    Detailed Transactions and Holdings:

    • Acquired 14,166 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 80,249.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 14,023 shares of Common Stock at $30.1637 per share (Direct)
      Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 66,226.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 143 shares of Common Stock at $31.0 per share (Direct)
      Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 66,083.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 245,308 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-05-01 | Code: M | Expires: 2030-02-03 | equity_swap_involved: false | shares_owned_after: 205,451.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 245,308 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-05-01 | Code: M | Expires: 2030-02-03 | equity_swap_involved: false | shares_owned_after: 205,308.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This is a scheduled exercise and sale from 10b5-1 trading plan.
    • F2: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
    • F3: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.00 to $30.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Search

News categories